User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Complement Enhances the Clearance of Large-sized Soluble Iga Aggregates in Rats

Primary tabs

Bogers, WMJM. Stad, RK. Janssen, DJ. Rits, M. Bazin, Hervé [UCL] Daha, MR.

In the present study the involvement of the complement system (C) in the clearance of soluble IgA aggregates in the rat was studied. Monoclonal monomeric IgA (mIgA) antibody (which does not activate C) or aggregated polymeric IgA (aIgA; which activates C) were administered intravenously to phosphate-buffered saline-treated and complement-depleted [Cobra venom factor (CVF)-treated] rats and assessed for clearance from the circulation. In the control rats, mIgA was cleared in a biphasic fashion with a first half-life (T1/2) of 29.5 +/- 14.2 min and a second T1/2 of 230 +/- 176 min. No differences were observed in clearance of mIgA in CVF-treated rats as compared to PBS-treated rats. In PBS-treated rats, aIgA with a size between 20S and 150S disappeared very rapidly from the circulation with a first T1/2 of 1.1 +/- 0.4 min and a second T1/2 of 23.2 +/- 11.3 min. In CVF-treated rats the clearance of aIgA was significantly delayed as compared to that in control rats, namely with a first T1/2 of 7.3 +/- 2.6 min and a second T1/2 of 64.2 +/- 19.4 min. Immunohistochemical studies of the liver (which is the main site of clearance of aIgA) revealed that Kupffer cells (KC) are mainly responsible for the uptake of aIgA. Furthermore, in PBS-treated rats aIgA deposition was accompanied by C3 deposition in the KC. In CVF-treated rats, the percentage of KC containing aIgA was significantly lower during the first 16 min after aIgA administration as compared to PBS treated rats. In addition no detectable C3 was found in KC of CVF-treated rats. These results indicate that KC plays an important role in the clearance of large molecular weight IgA in rats and that C facilitates the clearance of these complexes from the circulation.

Document type Article de périodique (Journal article) – Article de recherche
Publication date 1991
Language Anglais
Journal information "European Journal of Immunology" - Vol. 21, no. 5, p. 1093-1099 (1991)
Peer reviewed yes
Publisher Vch Publishers Inc (Deerfield Beach)
issn 0014-2980
e-issn 1521-4141
Publication status Publié
Affiliation UCL
Links
  1. Kauffmann, Am. J. Med., 69, 859 (1980)
  2. Coppo, Clin. Exp. Immunol., 57, 583 (1984)
  3. Lesavre, Clin. Exp. Immunol., 48, 61 (1982)
  4. Valentijn, Am. J. Med., 74, 375 (1983)
  5. Tomino, N. Engl. J. Med., 305, 1159 (1981)
  6. Valentijn, Kidney Int., 26, 760 (1984)
  7. Rauterberg, Kidney Int., 31, 820 (1987)
  8. Berger, Kidney Int., 7, 232 (1975)
  9. van den Wall Bake, Kidney Int., 35, 1400 (1989)
  10. Lopez Trascasa, Clin. Exp. Immunol., 42, 247 (1980)
  11. Czerkinsky, J. Clin. Invest., 77, 1931 (1986)
  12. Daha, Bailiere's Clin. Immunol. Allergy, 2, 505 (1988)
  13. Roccatello Dario, Picciotto Giuseppe, Coppo Rosanna, Piccoli Giuseppe, Molino Andrea, Cacace Giuseppe, Amore Alessandro, Amoroso Antonio, Quattrocchio Giacomo, Sena Luigi M., Clearance of Polymeric IgA Aggregates in Humans, 10.1016/s0272-6386(89)80167-2
  14. Rifai, Lab. Invest., 61, 381 (1989)
  15. Rifai, J. Immunol., 130, 1826 (1983)
  16. Rifai, J. Exp. Med., 160, 125 (1984)
  17. Skogh, Scand. J. Immunol., 16, 465 (1982)
  18. Phillips, Mol. Immunol., 25, 873 (1988)
  19. Egido, Immunology, 46, 1 (1982)
  20. Sancho, Immunology, 52, 161 (1984)
  21. Bogers, Immunology, 67, 274 (1989)
  22. Rifai, Kidney Int., 32, 838 (1987)
  23. Rits, J. Immunol. Methods, 89, 81 (1986)
  24. Rits, Scand. J. Immunol., 25, 359 (1987)
  25. Rits, Eur. J. Immunol., 18, 1873 (1988)
  26. Bogers, Scand. J. Immunol., 31, 679 (1990)
  27. Kimberley, J. Immunol., 137, 91 (1986)
  28. Clarkson, Exp. Med., 164, 474 (1986)
  29. Crofton, J. Exp. Med., 7, 1 (1978)
  30. Nishi, Lab. Invest., 44, 442 (1981)
  31. in (Ed.), Protides of the Biological Fluids, Pergamon Press, Oxford 1982, p. 615.
  32. Kints, J. Immunol. Methods, 119, 241 (1989)
  33. Kijlstra, J. Immunol., 17, 263 (1977)
  34. Gorter, Immunology, 64, 703 (1988)
  35. Veerhuis, Clin. Immunol. Immunopathol., 41, 379 (1986)
  36. in and (Eds.), Experimental Immunochemistry, Charles C. Thomas, Springfield 1961, p. 133.
  37. Dijkstra, Immunology, 54, 589 (1985)
  38. Daha, Immunology, 36, 63 (1979)
  39. Khalfan, Histochem. J., 18, 497 (1986)
  40. Kijlstra, Scand. J. Immunol., 10, 421 (1979)
  41. König, J. Immunol., 113, 501 (1974)
  42. Waxman, J. Clin. Invest., 74, 1329 (1984)
  43. Waxman, J. Clin. Invest., 77, 82 (1986)
  44. Cornacoff, J. Clin. Invest., 71, 236 (1983)
  45. Schifferli, N. Engl. J. Med., 315, 488 (1986)
  46. Bohnsack, J. Immunol., 143, 3338 (1989)
  47. Schneiderman, J. Immunol., 145, 233 (1990)
  48. Arend, J. Immunol., 107, 63 (1971)
  49. Sancho, Immunology, 57, 37 (1986)
  50. KOLB Helmut J., STANDL Eberhard, Purification to Homogeneity of an Insulin-Degrading Enzyme from Human Erythrocytes, 10.1515/bchm2.1980.361.2.1029
Bibliographic reference Bogers, WMJM. ; Stad, RK. ; Janssen, DJ. ; Rits, M. ; Bazin, Hervé ; et. al. Complement Enhances the Clearance of Large-sized Soluble Iga Aggregates in Rats. In: European Journal of Immunology, Vol. 21, no. 5, p. 1093-1099 (1991)
Permanent URL http://hdl.handle.net/2078.1/51109